Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV sildenafil in near-term and term newborns with persistent pulmonary hypertension of the newborn
2009-016248-37Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sildenafil in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Pfizer. Primary endpoint: Treatment failure incidence. Started Mar 2010; status: terminated.
02
Drugs
sildenafil
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on 2009-016248-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016248-37.